DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rose 1.64% to $229.41 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.38% to 51,850.55 and the S&P 500 Index falling 0.06% to 7,807.24.
This was the stock's second consecutive day of gains.
Biogen Inc. closed 0.47% below its 52-week high of $230.49, which the company reached on September 28th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.88% to $263.73, Pfizer Inc. $(PFE)$ rose 0.42% to $28.40, and AbbVie Inc. $(ABBV)$ rose 1.68% to $281.12.
Trading volume (1.5 M) eclipsed its 50-day average volume of 928,274.
Data source: Dow Jones Market Data, FactSet. Data compiled October 12, 2026.